journal article·2023-10

Induction of a different immune response in non-titanized compared to titanized polypropylene meshes

Oleksii Protsepko, Philipp Voisard, Christina Kuhn, Andrea Maccagno, Christian Dannecker, Udo Jeschke, Friedrich Pauli, Fabian Garrido

Acta Biomaterialia· Volume 169
Publisher page

Abstract

It is well known that pelvic organ prolapse (POP) significantly reduces the quality of life of affected women and in many cases requires corrective surgery. Aim of the study was to compare the immune response against titanized versus non-titanized meshes, especially macrophage polarization and immune checkpoint association. For this, we analyzed 644 POP surgeries, which were performed between 2017 and 2022, in our department. Four of them needed revision surgery caused by erosion. We analyzed the influx of CD68 & CD163 positive macrophages and the expression of immune checkpoint molecules PD-L1 and PD1 in these 4 patients. We identified a large number of CD68 and CD163 positive macrophages and additionally a PD-L1 expression of these cells. Based on the in-vivo results, we isolated monocytes and co-cultivated monocytes with different mesh material covered with or without fibroblasts. We identified a significantly enhanced macrophage activation and PD-L1 expression in macrophages surrounding non-titanized polypropylene mesh material. Encapsulation of the material by fibroblasts was crucial for that. Specifically, CD68-positive macrophages are upregulated (p < 0.001), co-expressing PD-L1 (p < 0.001) in monocytes co-cultivated with non-titanized polypropylene meshes. Monocytes co-cultivated with titanized polypropylene meshes showed significantly lower expression of CD163 (p = 0.027) and PD-L1 (p = 0.022). In conclusion, our in vitro data suggest that the titanium coating leads to a decreased polarization of macrophages and to a decreased immune response compared to non-titanized meshes. This could be an indication for the increased incidence of erosion of the non-titanized meshes, which is a severe complication of this procedure and requires revision surgery. STATEMENT OF SIGNIFICANCE: Pelvic organ prolapse is a well-known problem for women and often requires corrective surgery. Polypropylene meshes are often used, which differ in their coating (titanized vs. non-titanized). A severe side effect of these surgeries is mesh erosion, due to onset of inflammation, which requires revision surgery. We examined all erosion cases (4 of 644 patients) with implanted nontitanium-coated meshes by immunohistochemistry and found upregulation of macrophage polarization (as markers CD68 and CD163) and increased expression of the immune checkpoint molecules PD-L1 and PD1. This suggests inflammatory processes and an enhanced immune response. In addition, we set up an in vitro experiment to investigate whether coating plays a role. Here, we demonstrated that the non-titanized meshes elicited a significantly higher immune response in comparison to titanized meshes, which could lead to the higher erosion rate of the non-titanized meshes. Our results highlight the benefit of titanized meshes, which should lead to a lower revision surgery rate and thus improved patient outcome.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Pelvic floor disorders treatments · Anorectal Disease Treatments and Outcomes · Hernia repair and management

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (54)

Show source-provided references
1. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction10.1007/s00192-009-0976-9 ↗
2. Pelvic organ prolapse10.1016/S0140-6736(07)60462-0 ↗
3. N. Pelvic floor disorders, prevalence of symptomatic pelvic floor disorders in US women10.1001/jama.300.11.1311 ↗
4. Prevalence and trends of symptomatic pelvic floor disorders in U.S. women10.1097/AOG.0000000000000057 ↗
5. Symptomatic pelvic organ prolapse at midlife, quality of life, and risk factors10.1097/AOG.0b013e3181985312 ↗
6. Narrative review of the epidemiology, diagnosis and pathophysiology of pelvic organ prolapse10.1590/s1677-5538.ibju.2018.0581 ↗
7. Conservative prevention and management of pelvic organ prolapse in women
8. Ratio of women with POP using pessary, improvement in urination and quality of life10.56434/j.arch.esp.urol.20227505.64 ↗
9. Primary and repeat surgical treatment for female pelvic organ prolapse and incontinence in parous women in the UK: a register linkage study10.1136/bmjopen-2011-000206 ↗
10. Surgical management of vaginal prolapse: current surgical concepts
11. Guideline-based strategies in the surgical treatment of female urinary incontinence: the new gold standard is almost the same as the old one10.1055/s-0042-107079 ↗
12. Cadenbach-Blome · Geburtshilfe Frauenheilkd. · 2019 · 79 · 95910.1055/a-0984-6614 ↗
13. Mesh induced fibrosis: the protective role of T regulatory cells10.1016/j.actbio.2019.07.031 ↗
14. The programmed cell death protein 1 (PD1) and the programmed cell death ligand 1 (PD-L1) are significantly downregulated on macrophages and Hofbauer cells in the placenta of preeclampsia patients10.1016/j.jri.2023.103949 ↗
15. Relative contribution of direct and indirect allorecognition in developing tolerance after liver transplantation10.1002/lt.21378 ↗
16. Immune cell infiltrates as prognostic biomarkers in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis10.1002/cjp2.192 ↗
17. Tumor-associated macrophage infiltration and prognosis in colorectal cancer: systematic review and meta-analysis10.1007/s00384-020-03593-z ↗
18. Inhibitory receptors and pathways of lymphocytes: the role of PD-1 in treg development and their involvement in autoimmunity onset and cancer progression10.3389/fimmu.2018.02374 ↗
20. Time to rethink: an evidence-based response from pelvic surgeons to the FDA safety communication: "UPDATE on serious complications associated with transvaginal placement of surgical mesh for pelvic organ prolapse"10.1007/s00192-011-1581-2 ↗
21. [Use of synthetic slings and mesh implants in the treatment of female stress urinary incontinence and prolapse: Statement of the Working Group on Urological Functional Diagnostics and Female Urology of the Academy of the German Society of Urology]
22. Improvement of pelvic floor-related quality of life and sexual function after vaginal mesh implantation for cystocele: primary endpoint of a prospective multicentre trial10.1007/s00404-016-4014-0 ↗
23. Surgical intervention after transvaginal Prolift mesh repair: retrospective single-center study including 524 patients with 3 years' median follow-up10.1016/j.ajog.2011.07.040 ↗
24. Transvaginal repair of genital prolapse: preliminary results of a new tension-free vaginal mesh (Prolift technique)–a case series multicentric study10.1007/s00192-006-0234-3 ↗
25. Prolapse surgery in women of 80 years and older using the Prolift technique10.1007/s00192-010-1217-y ↗
26. Long-term (8.5 years) analysis of the type and rate of reoperation after transvaginal mesh repair (Prolift((R))) in 349 patients10.1016/j.ejogrb.2018.10.009 ↗
27. Macrophage polarisation: an immunohistochemical approach for identifying M1 and M2 macrophages10.1371/journal.pone.0080908 ↗
28. CCL22-polarized TAMs to M2a macrophages in cervical cancer in vitro model10.3390/cells11132027 ↗
29. Prostaglandin E2 receptor 3 promotes M1 macrophages polarization in unexplained recurrent pregnancy loss10.1093/biolre/ioac030 ↗
30. Updates of placental macrophages: origins, molecular markers, functions, and related diseases10.1016/j.jri.2023.103942 ↗
31. M2 macrophages infiltrating epithelial ovarian cancer express MDR1: a feature that may account for the poor prognosis10.3390/cells9051224 ↗
32. Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancer. Computer-assisted image analysis (QIC score) vs. subjective grading (IRS)10.1016/S0344-0338(11)81095-2 ↗
33. [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]
34. PD-L1-mediated immunosuppression in hepatocellular carcinoma: relationship with macrophages infiltration and inflammatory response activity10.3390/biom12091226 ↗
35. Two years follow up of 270 patients treated by transvaginal mesh for anterior and/or apical prolapse10.1016/j.ejogrb.2016.10.015 ↗
36. Programmed cell death-ligand-1 expression in bladder schistosomal squamous cell carcinoma - there's room for immune checkpoint blockage?10.3389/fimmu.2022.955000 ↗
37. Revisiting PD-1/PD-L pathway in T and B cell response: beyond immunosuppression10.1016/j.cytogfr.2022.07.003 ↗
38. Characterisation of the cellular infiltrate in the foreign body granuloma of textile meshes with its impact on collagen deposition10.1007/s10029-014-1220-1 ↗
39. Key players in the immune response to biomaterial scaffolds for regenerative medicine10.1016/j.addr.2017.07.006 ↗
40. Influence of polypropylene mesh degradation on tissue inflammatory reaction
41. FOXP3+ cells recruited by CCL22 into breast cancer correlates with less tumor nodal infiltration
42. Expression of CCL22 and infiltration by regulatory T cells are increased in the decidua of human miscarriage placentas10.1111/aji.12399 ↗
43. CCL1 is a major regulatory T cell attracting factor in human breast cancer10.1186/s12885-018-5117-8 ↗
44. The role of the immune checkpoint molecules PD-1/PD-L1 and TIM-3/Gal-9 in the pathogenesis of preeclampsia-a narrative review
45. The role of chemokines in cervical cancers
46. PD-L1 expression and survival in p16-negative and -positive squamous cell carcinomas of the vulva10.1007/s00432-020-03126-9 ↗
47. Comprehensive analysis of PD-L1 expression, HER2 amplification, ALK/EML4 fusion, and mismatch repair deficiency as putative predictive and prognostic factors in ovarian carcinoma10.1007/s00428-019-02528-6 ↗
48. Association between PD-1/PD-L1 and T regulate cells in early recurrent miscarriage
49. Myeloid-derived suppressor cells regulate the immunosuppressive functions of PD-1(-)PD-L1(+) Bregs through PD-L1/PI3K/AKT/NF-kappaB axis in breast cancer10.1038/s41419-021-03745-1 ↗
50. TiLoop(R) Bra mesh used for immediate breast reconstruction: comparison of retropectoral and subcutaneous implant placement in a prospective single-institution series10.1007/s00238-014-1001-1 ↗
51. TiLoop bra assisted breast reconstruction - our experience10.21614/chirurgia.116.2Suppl.S84 ↗
52. Prepectoral breast reconstruction with TiLoop(R) bra pocket: a single center prospective study
53. Prepectoral implant-based breast reconstruction with TiLOOP(R) Bra Pocket - a single-centre retrospective study10.1016/j.bjps.2021.08.027 ↗
54. Spatial and quantitative analysis of tumor-associated macrophages: intratumoral CD163-/PD-L1+ TAMs as a marker of favorable clinical outcomes in triple-negative breast cancer10.3390/ijms232113235 ↗